Ausgabe 6/2016
Inhalt (15 Artikel)
Inhibiting the PI3K signaling pathway: buparlisib as a new targeted option in breast carcinoma
L. G. Estévez, E. García, M. Hidalgo
Molecular biology of testicular germ cell tumors
R. Gonzalez-Exposito, M. Merino, C. Aguayo
Management of infection and febrile neutropenia in patients with solid cancer
J. A. Virizuela, J. Carratalà, J. M. Aguado, D. Vicente, M. Salavert, M. Ruiz, I. Ruiz, F. Marco, M. Lizasoain, P. Jiménez-Fonseca, C. Gudiol, J. Cassinello, A. Carmona-Bayonas, M. Aguilar, J. J. Cruz
Concurrent chemo-radiotherapy in elderly patients: tolerance and compliance in a series of 137 patients
M. Di Genesio Pagliuca, C. Perotti, G. Apicella, A. Galla, M. Guffi, M. Paolini, L. Donis, V. Amisano, S. Torrente, I. Manfredda, M. Krengli
Dual inhibiting EGFR and VEGF pathways versus EGFR-TKIs alone in the treatment of advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials
T. T. Zhang, R. M. Wang, Z. Yang, G. B. Chen
The position and current status of radiation therapy after primary systemic therapy in breast cancer: a national survey-based expert consensus statement
M. Arenas, Á. Montero, M. D. de las Peñas, M. Algara
The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma
J. Jia, Y. Cui, M. Lu, X. Wang, Jie Li, Jian Li, Y. Li, X. Zhang, J. Gao, J. Zhou, Z. Lu, J. Gong, J. Yu, Z. Sun, C. Liu, L. Shen, X. Zhang
Prognostic value of tropomyosin-related kinases A, B, and C in gastric cancer
A. Kamiya, M. Inokuchi, S. Otsuki, H. Sugita, K. Kato, H. Uetake, K. Sugihara, Y. Takagi, K. Kojima
Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy
D. Aydin, A. Bilici, S. Kayahan, D. Yavuzer, M. Basar, M. Aliustaoglu
The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients
M. Ozcelik, H. Odabas, O. Ercelep, S. Yuksel, A. G. Mert, D. Aydin, H. Surmeli, D. Isik, S. Isik, A. Oyman, B. B. Oven Ustaalioglu, M. Aliustaoglu, M. Gumus
Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy?
H. J. Park, K. Kim, J. H. Paik, E. K. Chie, S. Kim, J.-Y. Jang, S. W. Kim, S.-W. Han, D.-Y. Oh, S.-A. Im, T.-Y. Kim, Y.-J. Bang, S. W. Ha
Visceral obesity stimulates anaphase bridge formation and spindle assembly checkpoint dysregulation in radioresistant oesophageal adenocarcinoma
A. M. Mongan, N. Lynam-Lennon, R. Casey, S. Maher, G. Pidgeon, J. V. Reynolds, J. O’Sullivan
Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis
R.-H. Tian, Y.-G. Zhang, Z. Wu, X. Liu, J.-W. Yang, H.-L. Ji
Erratum to: Autologous tumor lysate/Bacillus Calmette–Guérin immunotherapy as an adjuvant to conventional breast cancer therapy
J. Convit, H. Montesinos, H. Oviedo, G. Romero, B. Maccarone, E. Essenfeld, A. Convit, L. E. Palacios
Erratum to: Visceral obesity stimulates anaphase bridge formation and spindle assembly checkpoint dysregulation in radioresistant oesophageal adenocarcinoma
A. M. Mongan, N. Lynam-Lennon, R. Casey, S. Maher, G. Pidgeon, J. V. Reynolds, J. O’Sullivan